[Clinical recommendations on the use of alemtuzumab (lemtrada)]

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(2. Vyp. 2):115-126. doi: 10.17116/jnevro201711722115-126.
[Article in Russian]
No abstract available

Keywords: alemtuzumab; monoclonal antibody; multiple sclerosis.

MeSH terms

  • Alemtuzumab* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Multiple Sclerosis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Alemtuzumab